Amisulpride
Product Specifications
CAS Number
71675-85-9
Target
Dopamine Receptor, 5-HT Receptor
Related Pathways
Neuroscience, GPCR/G Protein
Purity
0.9999
Bioactivity
Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban) . Amisulpride is a selective dopamine antagonist.
Smiles
C(NCC1N(CC)CCC1)(=O)C2=C(OC)C=C(N)C(S(CC)(=O)=O)=C2
Molecular Formula
C17H27N3O4S
Molecular Weight
369.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031674-PE 200 µL
AF9, CT (K486) (MLLT3, AF9, YEATS3, Protein AF-9, ALL1-fused gene from chromosome 9 protein, Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein, YEATS domain-containing protein 3) (PE) discontinued
Sign In for Pricing
View Details